Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients

By Lacha J.   Smova M.   Noskova L.   Teplan V.   Vtko S.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2273-2274

Elsevier

Access to resources Recommend Favorite

High-risk donors: expanding donor criteria

By Jordan M.L.   Shapiro R.   Vivas C.A.   Scantlebury V.P.   Corry R.J.   Randhawa P.   Hakala T.R.   Starzl T.E.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1401-1403

Elsevier

Access to resources Recommend Favorite

Characterization of High-Risk HIV-1 Seronegative Hemophiliacs

By Salkowitz J.R.   Purvis S.F.   Meyerson H.   Zimmerman P.   O'Brien T.R.   Aledort L.   Eyster M.E.   Hilgartner M.   Kessler C.   Konkle B.A.   White G.C.   Goedert J.J.   Lederman M.M.  

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 200-211

Academic Press

Access to resources Recommend Favorite

Focus on Five: High-risk Suicide Groups

By  

Joint Commission Perspectives on Patient Safety, Vol. 1, Iss. 3, 2001-07 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite

Lipid-Lowering Therapy in High-Risk Persons

By  

Comprehensive Therapy, Vol. 32, Iss. 2, 2006-06 ,pp. : 68-73

Humana Press, Inc

Access to resources Recommend Favorite